Komorita and other researchers discovered that serum FGF21 levels in MDM patients are significantly higher than in patients with other types of diabetes, suggesting that serum FGF21 could be used for preliminary screening of MDM (Komorita et al., 2023). The gene discussed is FGF21; the disease is diabetes mellitus.